Published February 9, 2021
| Version v1
Patent
Open
Methods and compositions involving RAD51 inhibitors
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
The present invention concerns methods and compositions involving inhibitors and of RAD51, a protein involved in homologous recombination. In some embodiments, there are methods for sensitizing cells to the effects of DNA damaging agents, which can have particular applications for cancer patients. In some embodiments of the invention, the RAD51 inhibitor is a small molecule that directly affects RAD51 activity, such as its ability to promote filament formation.
Files
US_10912761_B2.pdf
Files
(2.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:d8a1d68e201af5d7b6414b33f768a468
|
2.3 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 10912761 B2
- Patent application number
- 201314648115
- Other
- oai:uchicago.tind.io:9736
Dates
- Patent filed
-
2013-11-27